oxilorphan

RN given refers to cpd without isomeric designation

Also Known As:

L-N-cyclopropylmethyl-3,14-dihydroxymorphinan; oxilorphan hydrochloride; oxilorphan hydrochloride, (+-)-isomer; oxilorphan hydrochloride, (9alpha,13alpha,14alpha)-isomer; oxilorphan tartrate (2:1), (R-(R*,R*))-isomer; oxilorphan tartrate, (R-(R*,R*))-isomer; oxilorphan, (+-)-isomer; oxilorphan, (14alpha)-(+-)-isomer; oxilorphan, (14alpha)-isomer

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Miosis 04/01/1975 - "Duration studies in rodents were inconclusive, but in antagonism of morphine analgesia and miosis in the dog, oxilorphan was longer acting than naloxone and equivalent to dl-cyclazocine. "
2.	Diabetes Insipidus 01/01/1975 - "The diuretic action of two new narcotic antagonists, oxilorphan and butorphanol, was studied in rats heterozygous for hereditary hypothalmic diabetes insipidus. "

Related Drugs and Biologics

1.	Naloxone (Narcan)
2.	Morphine (MS Contin)
3.	Cyclazocine
4.	Narcotic Antagonists (Opioid Antagonists)
5.	Diuretics
6.	Butorphanol (BC 2627)

Related Therapies and Procedures

1.	Analgesia